Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

1.2K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
1.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Chemical Synapses01:26

Chemical Synapses

10.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.8K
Chemical Synapses01:26

Chemical Synapses

4.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.0K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.3K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anhidrosis: An underappreciated factor in dermatologic diseases.

Journal of the American Academy of Dermatology·2026
Same author

NeurAnki: Behind the Scenes of Creating the First-Ever Flashcard Based Deck for Resident Education (P12-5.009).

Neurology·2026
Same author

Workplace Lactation in Neurology: Barriers and Opportunities.

Neurology. Clinical practice·2026
Same author

Pure autonomic failure as an essential window into progression of synucleinopathies.

Brain : a journal of neurology·2026
Same author

Posterior fossa arachnoid cysts in multiple system atrophy.

IBRO neuroscience reports·2025
Same author

Implementing a Clinic Schedule with Protected Lactation Break Time Helps Neurology Residents Achieve Lactation Goals.

Journal of medical education and curricular development·2025
Same journal

Isolated Cranial Tremors: A Reappraisal.

Seminars in neurology·2026
Same journal

Dystonia and Tremor.

Seminars in neurology·2026
Same journal

Pendular nystagmus and oculopalatal tremor.

Seminars in neurology·2026
Same journal

Sanjay Pandey, MBBS, MD, DNB, DM, FIAN, and Aasef Shaikh, MD, PhD.

Seminars in neurology·2026
Same journal

Tremor.

Seminars in neurology·2026
Same journal

Carotid Disease.

Seminars in neurology·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.5K

Autonomic Dysfunction in the Synucleinopathies.

Elizabeth A Coon1

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota.

Seminars in Neurology
|September 9, 2020
PubMed
Summary
This summary is machine-generated.

Synucleinopathies like Parkinson's disease cause autonomic dysfunction. This review details autonomic failure in synucleinopathies, distinguishing central vs. peripheral types and outlining management strategies.

More Related Videos

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

818
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.0K

Related Experiment Videos

Last Updated: Dec 9, 2025

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.5K
Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

818
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.0K

Area of Science:

  • Neurology
  • Autonomic Neuroscience

Background:

  • Autonomic dysfunction is a hallmark of synucleinopathies.
  • Alpha-synuclein aggregation impacts autonomic system function differently across disorders.
  • Synucleinopathies include Parkinson's disease, dementia with Lewy bodies, pure autonomic failure, and multiple system atrophy.

Purpose of the Study:

  • To review the pathophysiology of autonomic failure in synucleinopathies.
  • To delineate clinical manifestations distinguishing synucleinopathy subtypes.
  • To provide management recommendations for autonomic dysfunction.

Main Methods:

  • Literature review focusing on pathophysiology, clinical features, and treatment.
  • Analysis of autonomic failure patterns in Lewy body disorders versus multiple system atrophy.
  • Synthesis of current non-pharmacologic and pharmacologic treatment approaches.

Main Results:

  • Lewy body disorders primarily exhibit peripheral autonomic failure.
  • Multiple system atrophy predominantly shows central autonomic failure.
  • Specific clinical and laboratory features aid in differentiating synucleinopathy subtypes.

Conclusions:

  • Understanding the distinct patterns of autonomic failure is crucial for diagnosing and managing synucleinopathies.
  • Tailored treatment strategies addressing underlying pathophysiology are essential.
  • Further research into targeted therapies for autonomic dysfunction in synucleinopathies is warranted.